Literature DB >> 10065326

Barrier mechanisms in the brain, II. Immature brain.

N R Saunders1, M D Habgood, K M Dziegielewska.   

Abstract

1. It is widely believed that 'the' blood-brain barrier is immature in foetuses and newborns. 2. Much evidence in support of this belief is based on experiments that were unphysiological and likely to have disrupted fragile blood vessels of the developing brain. Some confusion about barrier development arises from insufficient recognition that the term 'blood-brain barrier' describes a complex series of mechanisms controlling the internal environment of the brain. 3. We present evidence showing that the brain develops within an environment that, particularly with respect to protein, is different from that of the rest of the body and that possesses a number of unique features not present in the adult. 4. Barriers to protein at blood-brain and blood-cerebrospinal fluid (CSF) interfaces (tight junctions) are present from very early in development; immunocytochemical and permeability data show that proteins are largely excluded from extracellular space in developing brain. 5. Cerebrospinal fluid in developing brain contains high concentrations of proteins largely derived from plasma. This protein is transferred from blood by an intracellular mechanism across the epithelial cells of the immature choroid plexus. Only a small proportion of choroid plexus cells is involved. The route is an intracellular system of tubulo-endoplasmic reticulum continuously connected across the epithelial cells only early in brain development. 6. High concentrations of proteins in CSF in developing brain are largely excluded from the brain's extracellular space by barriers at the internal and external CSF-brain interfaces. These consist of membrane specializations between surfaces of cells forming these interfaces (neuroependyma on the inner surface; radial glial end feet on the outer surface). In contrast with tight junctions present at the blood-brain and blood-CSF barriers, at the CSF-brain barriers of the immature brain, other junctional types are involved: strap junctions in the neuroependyma and a mixture of junctions at the outer CSF-brain barrier (plate junctions, strap junctions and wafer junctions). These barriers are not present in the adult. 7. Permeability to small lipid-insoluble molecules is greater in developing brain; more specific mechanisms, such as those involved in transfer of ions and amino acids, develop sequentially as the brain grows.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10065326     DOI: 10.1046/j.1440-1681.1999.02987.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  51 in total

Review 1.  The nature and composition of the internal environment of the developing brain.

Authors:  K M Dziegielewska; G W Knott; N R Saunders
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

Review 2.  Barriers in the immature brain.

Authors:  N R Saunders; G W Knott; K M Dziegielewska
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

Review 3.  Newborn screening for neuropathic lysosomal storage disorders.

Authors:  Wuh-Liang Hwu; Yin-Hsiu Chien; Ni-Chung Lee
Journal:  J Inherit Metab Dis       Date:  2010-06-08       Impact factor: 4.982

4.  Formation and structural organization of the barrier on the outer surface of the brain.

Authors:  V A Otellin; D E Korzhevskii
Journal:  Neurosci Behav Physiol       Date:  2004-05

Review 5.  The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system.

Authors:  David C Clark; Aaron C Brault; Elizabeth Hunsperger
Journal:  Arch Virol       Date:  2012-05-17       Impact factor: 2.574

6.  Pharmacokinetics of penicillin g in very-low-birth-weight neonates.

Authors:  Tuuli Metsvaht; Kersti Oselin; Mari-Liis Ilmoja; Kaili Anier; Irja Lutsar
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

7.  AAV9: a potential blood-brain barrier buster.

Authors:  Fredric P Manfredsson; Aaron C Rising; Ronald J Mandel
Journal:  Mol Ther       Date:  2009-03       Impact factor: 11.454

Review 8.  Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.

Authors:  Sonu Bhaskar; Furong Tian; Tobias Stoeger; Wolfgang Kreyling; Jesús M de la Fuente; Valeria Grazú; Paul Borm; Giovani Estrada; Vasilis Ntziachristos; Daniel Razansky
Journal:  Part Fibre Toxicol       Date:  2010-03-03       Impact factor: 9.400

9.  Manual drainage of the zebrafish embryonic brain ventricles.

Authors:  Jessica T Chang; Hazel Sive
Journal:  J Vis Exp       Date:  2012-12-16       Impact factor: 1.355

Review 10.  Toxicology of avermectins and milbemycins (macrocylic lactones) and the role of P-glycoprotein in dogs and cats.

Authors:  Valentina M Merola; Paul A Eubig
Journal:  Vet Clin North Am Small Anim Pract       Date:  2012-03       Impact factor: 2.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.